« Back
Home /
Recombinant Human VEGFR3/FLT4 Protein (His Tag), HPLC-verified

Recombinant Human VEGFR3/FLT4 Protein (His Tag), HPLC-verified

Item no.	10806-H08H-4
Manufacturer	Sino Biological
Amount	4 mg
Quantity options	1 mg 100 ug 2 mg 4 mg 50 ug
Category	Oncology By Cell Type Blastoma Carcinoma Hematology Lymphoma Myeloma Melanoma Sarcoma Peptides & Proteins Recombinant Proteins Cell Biology Cell Movement Cell Adhesion Cell Culture Cytokines Adenocarcinoma Mesothelioma By Organ Bladder Cancer
Type	Proteins
Specific against	Human (Homo sapiens)
Host	Human
Conjugate/Tag	HIS
Purity	> 97 % as determined by SDS-PAGE
Sequence	Met1-Ile776
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	FLT-4,FLT-41,FLT41,LMPH1A,PCL,VEGFR-3,VEGFR3
Similar products	FLT4
Available
Manufacturer - Type	Protein
Manufacturer - Conjugate / Tag	C-His
Shipping Temperature	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage Conditions	Store it under sterile conditions at -20C to -80C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Antigen molecule name	FLT4
Protein Construction	A DNA sequence encoding the extracellular domain (Met 1-Ile 776) of human VEGFR3 (NP_002011.2) was expressed with a C-terminal polyhistidine tag.
Expressed Host	Human Cells
Bio-Activity	1. Measured by its binding ability in a functional ELISA. 2. Immobilized human VEGF-C (Cat: 10542-H08H) at 10 ug/mL (100 ul/well) can bind human VEGFR3-his. The EC50 of human VEGFR3-his is 0.011 ug/mL. 3. Measured by its ability to bind human VEGF-D (Cat: 10557-H08H) in a functional ELISA.
Endotoxin	< 1.0 EU per ug of the protein as determined by the LAL method
Predicted N Terminal	Tyr 25 & Ser 473
Molecule Mass	The recombinant human VEGF R3 consists of 763 amino acids and predicts a molecular mass of 86 kDa. As a result of glycosylation, rhVEGFR3 migrates as an approximately 130 kDa in non-reduced SDS-PAGE.
Formulation	Lyophilized from sterile PBS, pH 7.4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

10806-H08H-4-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 4 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question